NGNE
Income statement / Annual
Last year (2025), Neurogene Inc's total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2025, Neurogene Inc's net income was -$90.35 M.
See Neurogene Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$925.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$25.00 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$3.19 M
|
$3.25 M
|
$3.26 M
|
$3.20 M
|
$42.26 M
|
$1.82 M
|
$340.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$3.19 M
|
-$2.32 M
|
-$3.26 M
|
-$3.20 M
|
-$42.26 M
|
-$1.82 M
|
-$340.00 K
|
$25.00 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
-2.51
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
| Research and Development Expenses |
$75.01 M
|
$60.92 M
|
$44.39 M
|
$47.51 M
|
$42.26 M
|
$24.34 M
|
$6.32 M
|
$32.79 M
|
$36.27 M
|
$28.38 M
|
| General & Administrative Expenses |
$0.00
|
$22.61 M
|
$11.19 M
|
$9.01 M
|
$8.27 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$25.13 M
|
$22.61 M
|
$11.19 M
|
$9.01 M
|
$8.27 M
|
$15.39 M
|
$17.79 M
|
$15.74 M
|
$14.85 M
|
$9.26 M
|
| Other Expenses |
$0.00
|
-$3.25 M
|
-$3.26 M
|
-$3.20 M
|
-$42.26 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$100.02 M
|
$80.28 M
|
$52.32 M
|
$53.32 M
|
$8.27 M
|
$39.73 M
|
$24.10 M
|
$48.52 M
|
$51.12 M
|
$37.65 M
|
| Cost And Expenses |
$103.21 M
|
$83.53 M
|
$55.58 M
|
$56.52 M
|
$50.53 M
|
$41.55 M
|
$24.44 M
|
$48.52 M
|
$51.12 M
|
$37.65 M
|
| Interest Income |
$11.55 M
|
$8.47 M
|
$2.95 M
|
$1.34 M
|
$19.00 K
|
$490.00 K
|
$1.54 M
|
$1.56 M
|
$998.00 K
|
$619.00 K
|
| Interest Expense |
$5.00 K
|
$12.00 K
|
$12.00 K
|
$2.00 K
|
$0.00
|
$0.00
|
$1.00 K
|
$4.00 K
|
$4.00 K
|
$1.00 K
|
| Depreciation & Amortization |
$3.09 M
|
$3.25 M
|
$3.30 M
|
$3.20 M
|
$947.00 K
|
$1.82 M
|
$340.00 K
|
$0.00
|
$0.00
|
$0.00
|
| EBITDA |
-$87.25 M |
-$71.89 M |
-$33.01 M |
-$51.99 M |
-$49.57 M |
-$31.46 M |
-$69.10 M |
-$31.58 M |
-$50.18 M |
-$37.00 M |
| EBITDA Ratio |
0
|
-77.71
|
0
|
0
|
0
|
0
|
0
|
-1.26
|
0
|
0
|
| Operating Income Ratio |
0
|
-89.3
|
0
|
0
|
0
|
0
|
0
|
-0.94
|
0
|
0
|
| Total Other Income/Expenses Net |
$12.86 M
|
$7.46 M
|
$19.27 M
|
$1.33 M
|
$17.00 K
|
$8.28 M
|
-$45.00 M
|
-$8.06 M
|
$936.00 K
|
$643.00 K
|
| Income Before Tax |
-$90.35 M
|
-$75.14 M
|
-$36.32 M
|
-$55.19 M
|
-$50.52 M
|
-$33.28 M
|
-$69.44 M
|
-$31.59 M
|
-$50.18 M
|
-$37.00 M
|
| Income Before Tax Ratio |
0
|
-81.24
|
0
|
0
|
0
|
0
|
0
|
-1.26
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$90.35 M
|
-$75.14 M
|
-$36.32 M
|
-$55.19 M
|
-$50.52 M
|
-$33.28 M
|
-$69.44 M
|
-$31.59 M
|
-$50.18 M
|
-$37.00 M
|
| Net Income Ratio |
0
|
-81.24
|
0
|
0
|
0
|
0
|
0
|
-1.26
|
0
|
0
|
| EPS |
-4.24 |
-4.28 |
-2.83 |
-4.3 |
-0.92 |
-0.64 |
-2.57 |
-1.34 |
-2.14 |
-1.96 |
| EPS Diluted |
-4.24 |
-4.28 |
-2.83 |
-4.3 |
-0.92 |
-0.64 |
-2.57 |
-1.34 |
-2.14 |
-1.96 |
| Weighted Average Shares Out |
$21.17 M
|
$17.57 M
|
$12.82 M
|
$12.82 M
|
$55.04 M
|
$51.83 M
|
$27.03 M
|
$23.52 M
|
$23.45 M
|
$18.89 M
|
| Weighted Average Shares Out Diluted |
$21.17 M
|
$17.57 M
|
$12.82 M
|
$12.82 M
|
$55.04 M
|
$51.83 M
|
$27.03 M
|
$23.52 M
|
$23.45 M
|
$18.89 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
